.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Pharmaceutical residues like antidepressants frequently enter aquatic environments through wastewater. Consequently, scientists are exploring efficient removal methods to protect public health. A recent study investigated antidepressant degradation in UV-AOPs to understand how these drugs transform during water treatment. Researchers specifically examined the effectiveness of UV/hydrogen peroxide (UV/H2O2) and UV/peroxydisulfate (UV/PDS) processes.
The study found that both UV-AOPs significantly improved degradation rates compared to direct photolysis. For instance, pseudo-first-order rate constants increased by up to 105.19-fold. Moreover, most antidepressants reacted faster with hydroxyl radicals than with sulfate radicals. Notably, halogenated drugs like fluoxetine underwent effective dehalogenation during the process. While UV/PDS showed stronger dehalogenation capabilities, it also increased the risk of producing trifluoroacetic acid (TFA), which is a persistent environmental pollutant.
Furthermore, the degradation pathways primarily involved dealkylation and hydroxylation. Most resulting intermediates exhibited lower acute toxicity and reduced bioaccumulation potential. However, the long-term risks of metabolites like TFA remain a concern for environmental health professionals. These findings provide a foundation for developing better advanced oxidation processes to safeguard our water supplies.
UV-AOPs significantly accelerate the breakdown of antidepressants in water. They often achieve degradation rates over 100 times faster than natural light exposure alone.
Most intermediates show reduced acute toxicity. However, some processes may generate persistent substances like trifluoroacetic acid. This metabolite requires further long-term risk assessment for aquatic life and human consumption.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Ren W et al. Transformation characteristics of typical antidepressants in UV-advanced oxidation processes. J Hazard Mater. 2026 Jun 08. doi: undefined. PMID: 42258980.
2. Ahmed HR et al. Advanced oxidation processes for the removal of antidepressants from wastewater: a comprehensive review. RSC Publishing. 2025 Dec 08. DOI: 10.1039/D5EW00234K.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A new study reveals how UV-AOPs effectively degrade antidepressants like fluoxetine, highlighting dehalogenation efficiency and the risk of TFA formation....
3 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
